Report Overview
Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.
The global Peptide Receptor Radionuclide Therapy (PRRT) market size was estimated at USD 1043 million in 2023 and is projected to reach USD 4418.73 million by 2032, exhibiting a CAGR of 17.40% during the forecast period.
North America Peptide Receptor Radionuclide Therapy (PRRT) market size was estimated at USD 358.89 million in 2023, at a CAGR of 14.91% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Peptide Receptor Radionuclide Therapy (PRRT) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide Receptor Radionuclide Therapy (PRRT) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide Receptor Radionuclide Therapy (PRRT) market in any manner.
Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
Curium Pharmaceuticals
Market Segmentation (by Type)
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peptide Receptor Radionuclide Therapy (PRRT) Market
Overview of the regional outlook of the Peptide Receptor Radionuclide Therapy (PRRT) Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peptide Receptor Radionuclide Therapy (PRRT)
1.2 Key Market Segments
1.2.1 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Type
1.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peptide Receptor Radionuclide Therapy (PRRT) Market Overview
2.1 Global Market Overview
2.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peptide Receptor Radionuclide Therapy (PRRT) Market Competitive Landscape
3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales by Manufacturers (2019-2025)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Manufacturers (2019-2025)
3.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Peptide Receptor Radionuclide Therapy (PRRT) Sales Sites, Area Served, Product Type
3.6 Peptide Receptor Radionuclide Therapy (PRRT) Market Competitive Situation and Trends
3.6.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Peptide Receptor Radionuclide Therapy (PRRT) Industry Chain Analysis
4.1 Peptide Receptor Radionuclide Therapy (PRRT) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peptide Receptor Radionuclide Therapy (PRRT) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Peptide Receptor Radionuclide Therapy (PRRT) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Type (2019-2025)
6.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2019-2025)
6.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Price by Type (2019-2025)
7 Peptide Receptor Radionuclide Therapy (PRRT) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Sales by Application (2019-2025)
7.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (M USD) by Application (2019-2025)
7.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Growth Rate by Application (2019-2025)
8 Peptide Receptor Radionuclide Therapy (PRRT) Market Consumption by Region
8.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales by Region
8.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales by Region
8.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide Receptor Radionuclide Therapy (PRRT) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Peptide Receptor Radionuclide Therapy (PRRT) Market Production by Region
9.1 Global Production of Peptide Receptor Radionuclide Therapy (PRRT) by Region (2019-2025)
9.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Region (2019-2025)
9.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Production
9.4.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Production Growth Rate (2019-2025)
9.4.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Peptide Receptor Radionuclide Therapy (PRRT) Production
9.5.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Production Growth Rate (2019-2025)
9.5.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Peptide Receptor Radionuclide Therapy (PRRT) Production (2019-2025)
9.6.1 Japan Peptide Receptor Radionuclide Therapy (PRRT) Production Growth Rate (2019-2025)
9.6.2 Japan Peptide Receptor Radionuclide Therapy (PRRT) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Peptide Receptor Radionuclide Therapy (PRRT) Production (2019-2025)
9.7.1 China Peptide Receptor Radionuclide Therapy (PRRT) Production Growth Rate (2019-2025)
9.7.2 China Peptide Receptor Radionuclide Therapy (PRRT) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Bayer
10.1.1 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
10.1.2 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
10.1.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer Peptide Receptor Radionuclide Therapy (PRRT) SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Novartis
10.2.1 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
10.2.2 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
10.2.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis Peptide Receptor Radionuclide Therapy (PRRT) SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Lantheus
10.3.1 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
10.3.2 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
10.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Market Performance
10.3.4 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) SWOT Analysis
10.3.5 Lantheus Business Overview
10.3.6 Lantheus Recent Developments
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
10.4.2 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
10.4.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Market Performance
10.4.4 Aurobindo Pharma Business Overview
10.4.5 Aurobindo Pharma Recent Developments
10.5 Mundipharma
10.5.1 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
10.5.2 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
10.5.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Market Performance
10.5.4 Mundipharma Business Overview
10.5.5 Mundipharma Recent Developments
10.6 Curium Pharmaceuticals
10.6.1 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
10.6.2 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
10.6.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Market Performance
10.6.4 Curium Pharmaceuticals Business Overview
10.6.5 Curium Pharmaceuticals Recent Developments
11 Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Region
11.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast
11.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Country
11.2.3 Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Region
11.2.4 South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Peptide Receptor Radionuclide Therapy (PRRT) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Peptide Receptor Radionuclide Therapy (PRRT) by Type (2025-2032)
12.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Peptide Receptor Radionuclide Therapy (PRRT) by Type (2025-2032)
12.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Application (2025-2032)
12.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT) Forecast by Application
12.2.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peptide Receptor Radionuclide Therapy (PRRT) Market Size Comparison by Region (M USD)
Table 5. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2022)
Table 10. Global Market Peptide Receptor Radionuclide Therapy (PRRT) Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Peptide Receptor Radionuclide Therapy (PRRT) Sales Sites and Area Served
Table 12. Manufacturers Peptide Receptor Radionuclide Therapy (PRRT) Product Type
Table 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peptide Receptor Radionuclide Therapy (PRRT)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges
Table 22. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales by Type (K MT)
Table 23. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (M USD)
Table 24. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT) by Type (2019-2025)
Table 25. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Type (2019-2025)
Table 26. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (M USD) by Type (2019-2025)
Table 27. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Type (2019-2025)
Table 28. Global Peptide Receptor Radionuclide Therapy (PRRT) Price (USD/MT) by Type (2019-2025)
Table 29. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT) by Application
Table 30. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
Table 31. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales by Application (2019-2025) & (K MT)
Table 32. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Application (2019-2025)
Table 33. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales by Application (2019-2025) & (M USD)
Table 34. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2019-2025)
Table 35. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Growth Rate by Application (2019-2025)
Table 36. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales by Region (2019-2025) & (K MT)
Table 37. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Region (2019-2025)
Table 38. North America Peptide Receptor Radionuclide Therapy (PRRT) Sales by Country (2019-2025) & (K MT)
Table 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Sales by Region (2019-2025) & (K MT)
Table 41. South America Peptide Receptor Radionuclide Therapy (PRRT) Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Sales by Region (2019-2025) & (K MT)
Table 43. Global Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT) by Region (2019-2025)
Table 44. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Region (2019-2025)
Table 46. Global Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
Table 52. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
Table 53. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Bayer Business Overview
Table 55. Bayer Peptide Receptor Radionuclide Therapy (PRRT) SWOT Analysis
Table 56. Bayer Recent Developments
Table 57. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
Table 58. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
Table 59. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Novartis Business Overview
Table 61. Novartis Peptide Receptor Radionuclide Therapy (PRRT) SWOT Analysis
Table 62. Novartis Recent Developments
Table 63. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
Table 64. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
Table 65. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) SWOT Analysis
Table 67. Lantheus Business Overview
Table 68. Lantheus Recent Developments
Table 69. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
Table 70. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
Table 71. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Aurobindo Pharma Business Overview
Table 73. Aurobindo Pharma Recent Developments
Table 74. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
Table 75. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
Table 76. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Mundipharma Business Overview
Table 78. Mundipharma Recent Developments
Table 79. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Basic Information
Table 80. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Overview
Table 81. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Curium Pharmaceuticals Business Overview
Table 83. Curium Pharmaceuticals Recent Developments
Table 84. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Peptide Receptor Radionuclide Therapy (PRRT) Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Peptide Receptor Radionuclide Therapy (PRRT)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (M USD), 2019-2032
Figure 5. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (M USD) (2019-2032)
Figure 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (M USD)
Figure 11. Peptide Receptor Radionuclide Therapy (PRRT) Sales Share by Manufacturers in 2023
Figure 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Manufacturers in 2023
Figure 13. Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peptide Receptor Radionuclide Therapy (PRRT) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type
Figure 18. Sales Market Share of Peptide Receptor Radionuclide Therapy (PRRT) by Type (2019-2025)
Figure 19. Sales Market Share of Peptide Receptor Radionuclide Therapy (PRRT) by Type in 2023
Figure 20. Market Size Share of Peptide Receptor Radionuclide Therapy (PRRT) by Type (2019-2025)
Figure 21. Market Size Market Share of Peptide Receptor Radionuclide Therapy (PRRT) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application
Figure 24. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Application (2019-2025)
Figure 25. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Application in 2023
Figure 26. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2019-2025)
Figure 27. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application in 2023
Figure 28. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Region (2019-2025)
Figure 30. North America Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country in 2023
Figure 32. U.S. Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Peptide Receptor Radionuclide Therapy (PRRT) Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country in 2023
Figure 37. Germany Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Region in 2023
Figure 44. China Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (K MT)
Figure 50. South America Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country in 2023
Figure 51. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Peptide Receptor Radionuclide Therapy (PRRT) Production Market Share by Region (2019-2025)
Figure 62. North America Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT) Growth Rate (2019-2025)
Figure 65. China Peptide Receptor Radionuclide Therapy (PRRT) Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share Forecast by Type (2025-2032)
Figure 70. Global Peptide Receptor Radionuclide Therapy (PRRT) Sales Forecast by Application (2025-2032)
Figure 71. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share Forecast by Application (2025-2032)
